ESPEROCT

NDC 0169-8150 · Novo Nordisk

Generic nameantihemophilic factor (recombinant), glycopegylated-exei

Dosage formKIT

Marketing categoryBLA

Packages

0169-8150-01 — 1 KIT in 1 KIT (0169-8150-01) * 4 mL in 1 VIAL, GLASS (0169-8151-11) * 4 mL in 1 SYRINGE, GLASS (0169-8008-98)

Billed under HCPCS

J7204 — Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu Medicare Part B payment limit (ASP + 6%): $2.30

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.